Disappearance of Serum Methylated p16 Indicates Longer Survival in Patients with Gastric Cancer

Purpose The aim of this study was to assess clinical correlations with postoperative alteration of p16 DNA methylation, and to clarify whether postoperative changes in the serum DNA methylation status of p16 could be used as a reliable prognostic factor for gastric cancer. Materials and Methods Fifty-three consecutive gastric adenocarcinoma patients who underwent gastric resection (Chung-Ang University Hospital, Seoul, Korea) were included. DNA methylation of p16 was evaluated by methylation-specific polymerase chain reaction using serum DNA preoperatively and at the 10th postoperative day. The correlation between changes in methylation status and patients' prognosis was analyzed. Results p16 was methylated in 79.2% of preoperative serum DNA and in 54.7% of postoperative serum DNA, respectively. Methylation in p16 disappeared more frequently in patients who underwent standard D2 lymphadenectomy compared to those who underwent modified D1+ lymphadenectomy (P=0.016). Whereas methylation of preoperative serum DNA was not correlated with survival, patients with postoperative disappearance of p16 methylation showed longer survival than those without postoperative disappearance of p16 methylation in the patients who had gastric cancer with lymph node metastasis (P=0.042). Conclusions Postoperative disappearance of p16 methylation could be an available prognostic factor for node-positive gastric cancer.

[1]  H. Nemoto,et al.  Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer. , 2010, Anticancer research.

[2]  K. Miyazaki,et al.  Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients , 2007, Journal of Gastroenterology.

[3]  D. Ichikawa,et al.  Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer. , 2007, Hepato-Gastroenterology.

[4]  Hiroki Kuniyasu,et al.  Accumulation of DNA methylation is associated with tumor stage in gastric cancer , 2006, Cancer.

[5]  Jong-Han Kim,et al.  Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection. , 2006, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  F. Chan,et al.  Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer , 2005, British Journal of Cancer.

[7]  J. Ajani,et al.  Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  P. Nightingale,et al.  Improving outcomes in gastric cancer over 20 years , 2004, Gastric Cancer.

[9]  Tsung-Teh Wu,et al.  Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas , 2004, Oncogene.

[10]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[11]  Hwoong-Yong Jung,et al.  Profile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric Carcinogenesis , 2003, Laboratory Investigation.

[12]  W. Leung,et al.  Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  H. Yokozaki,et al.  Promoter Methylation Status of the DNA Repair Genes hMLH1 and MGMT in Gastric Carcinoma and Metaplastic Mucosa , 2002, Pathobiology.

[14]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[15]  N. Tomita,et al.  Expression of Tumor Suppressor Gene p16INK4 Products in Primary Gastric Cancer , 2000, Oncology.

[16]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[17]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[18]  J. Jen,et al.  Molecular detection of genetic alterations in the serum of colorectal cancer patients. , 1998, Cancer research.

[19]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Cassoni.  Tnm Classification of Malignant Tumours , 1987 .

[21]  W. Liu,et al.  Prognostic significance of aberrant gene methylation in gastric cancer. , 2012, American journal of cancer research.

[22]  辻江 正樹.  Expression of tumor suppressor gene p16[INK4] products in primary gastric canser , 2000 .

[23]  W. Lau,et al.  Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. , 1999, Cancer research.

[24]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.